{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T22:42:38Z","timestamp":1790030558692,"version":"4.0.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"41","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.vaccine.2016.08.062","type":"journal-article","created":{"date-parts":[[2016,9,3]],"date-time":"2016-09-03T00:12:16Z","timestamp":1472861536000},"page":"4892-4897","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Patterns of spontaneous reports on narcolepsy following administration of pandemic influenza vaccine; a case series of individual case safety reports in Eudravigilance"],"prefix":"10.1016","volume":"34","author":[{"given":"Kartini","family":"Gadroen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine M.J.M.","family":"Straus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Pacurariu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Weibel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Kurz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam C.J.M.","family":"Sturkenboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.08.062_b0005","unstructured":"Chan M. World now at the start of 2009 influenza pandemic. Statement to the press by WHO Director-General Dr Margaret Chan. Statement to the press by WHO Director-General Dr Margaret Chan. World Health Organization; 2009."},{"key":"10.1016\/j.vaccine.2016.08.062_b0010","unstructured":"ECDC. Enhanced monitoring of vaccine safety for 2009 pandemic vaccines."},{"key":"10.1016\/j.vaccine.2016.08.062_b0015","series-title":"Narcolepsy in association with pandemic influenza vaccination (a multi-country European epidemiological investigation)","author":"ECDC","year":"2012"},{"key":"10.1016\/j.vaccine.2016.08.062_b0020","first-page":"17","article-title":"Influenza A(H1N1)pdm09 vaccination policies and coverage in Europe","author":"Mereckiene","year":"2012","journal-title":"Euro surveillance: Bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin"},{"key":"10.1016\/j.vaccine.2016.08.062_b0025","unstructured":"European Medicines Agency policy on access to Eudravigilance data for medicinal products for human use. London: European Medicines Agency (EMA); 2015."},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2016.08.062_b0030","doi-asserted-by":"crossref","first-page":"B6","DOI":"10.1016\/j.vaccine.2015.03.026","article-title":"The narcolepsy-pandemic influenza story: can the truth ever be unraveled?","volume":"33","author":"Sturkenboom","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.08.062_b0035","series-title":"Pandemic report and lessons learned; outcome of the European Medicines Agency activities during the (H1N1) flu pandemic","first-page":"2011","author":"EMA","year":"2009"},{"key":"10.1016\/j.vaccine.2016.08.062_b0040","unstructured":"VAESCO. VAESCO Background rates. Vaccine Adverse Event Surveillance and Communication (VAESCO)."},{"key":"10.1016\/j.vaccine.2016.08.062_b0045","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.1016\/j.vaccine.2011.04.005","article-title":"Safety monitoring of Influenza A\/H1N1 pandemic vaccines in Eudravigilance","volume":"29","author":"Kurz","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.08.062_b0050","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/apa.12012","article-title":"The Pandemrix \u2013 narcolepsy tragedy: how it started and what we know today","volume":"102","author":"Kall","year":"2013","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.vaccine.2016.08.062_b0055","unstructured":"Yle Uutiset News. Minister calls for thorough examination of possible link between H1N1 and narcolepsy. Yle Finland\u2019s National Public Service Broadcasting Company; 2010."},{"key":"10.1016\/j.vaccine.2016.08.062_b0060","unstructured":"EMA. European Medicines Agency starts review of Pandemrix European Medicines Agency (EMA); 2010."},{"key":"10.1016\/j.vaccine.2016.08.062_b0065","unstructured":"Regulation (EU) no 1027\/2012 of the European Parliament and of the Council of 25 October 2012 amending Regulation (EC) No 726\/2004 as regards pharmacovigilance."},{"key":"10.1016\/j.vaccine.2016.08.062_b0070","unstructured":"Directive 2012\/26\/EU of the European Parliament and of the Council of 25 October 2012 amending Directive 2001\/83\/EC as regards pharmacovigilance."},{"key":"10.1016\/j.vaccine.2016.08.062_b0075","unstructured":"EMA. Good pharmacovigilance practices. London: European Medicines Agency (EMA)."},{"key":"10.1016\/j.vaccine.2016.08.062_b0080","unstructured":"Group IEW. ICH harmonised tripartite guideline. Data elements for transmission of Individual Case Safety Reports E2B (R2); 2001."},{"key":"10.1016\/j.vaccine.2016.08.062_b0085","unstructured":"Heads of Medicines Agencies (HMA). EU Individual Case Safety Report (ICSR) Implementation Guide. Heads of Medicines Agencies (HMA), European Medicines Agency (EMA); 2014."},{"key":"10.1016\/j.vaccine.2016.08.062_b0090","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.vaccine.2012.12.014","article-title":"Narcolepsy as an adverse event following immunization: case definition and guidelines for data collection, analysis and presentation","volume":"31","author":"Poli","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.08.062_b0095","unstructured":"Brighton Collaboration. Resources. ABC Tool."},{"key":"10.1016\/j.vaccine.2016.08.062_b0100","first-page":"2","article-title":"Position and processing of adverse drug reactions directly submitted by patients to national regulatory authorities","author":"Srba","year":"2014","journal-title":"Eur J Pharmacovigilance"},{"key":"10.1016\/j.vaccine.2016.08.062_b0105","doi-asserted-by":"crossref","first-page":"f5645","DOI":"10.1136\/bmj.f5645","article-title":"UK government is to reconsider claims of children who developed narcolepsy after vaccination","volume":"347","author":"Dyer","year":"2013","journal-title":"BMJ"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16307587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16307587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T11:16:10Z","timestamp":1556363770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16307587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":21,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0264410X16307587"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.08.062","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patterns of spontaneous reports on narcolepsy following administration of pandemic influenza vaccine; a case series of individual case safety reports in Eudravigilance","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.08.062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}